FDA
approval
· 2020-08-06
FDA Approved: NARCAN — Supplemental Application (Emergent Devices Inc.)
Summary
The FDA approved a supplemental application for NARCAN (naloxone hydrochloride nasal spray) submitted by Emergent Devices Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NARCAN (NALOXONE HYDROCHLORIDE NASAL)